Procter & Gamble (NYSE:PG | PG Price Prediction) and Colgate-Palmolive (NYSE:CL) both posted top and bottom line beats in their most recent quarters.
Colgate-Palmolive (CL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
CL stock's strength reflects solid momentum, but inflation, North America softness and a premium valuation could keep new buyers waiting.
Procter & Gamble (NYSE:PG | PG Price Prediction) and Colgate-Palmolive (NYSE:CL) both just reported, and the earnings reports sharpened a debate dividend investors have been having for years.
CL leverages pricing power, premium innovation and productivity initiatives to drive growth, expand margins and strengthen brand momentum.
Procter & Gamble (NYSE:PG | PG Price Prediction) is the household name every retirement portfolio reaches for when markets get choppy, and its $350.4 billion market cap makes it the default consumer defensive trade on every desk.
Many market analysts believe the current environment of entrenched inflation and higher-for-longer interest rates will be a headwind on the economy into 2027. That combination has made dividend stocks less attractive in recent years.
Consumer confidence is softening into the back half of spring, and the rotation out of growth and into recession-resistant cash flow is picking up speed.
Colgate-Palmolive Company (CL) Presents at 23rd annual dbAccess Global Consumer Conference Transcript
CL balances pricing and volume growth as emerging markets and innovation support sales momentum.
CL's innovation strategy is driving market share gains as premium launches, pricing and science-based products support growth across oral care and pet nutrition.
Colgate-Palmolive (NYSE:CL | CL Price Prediction) is exactly the kind of name investors hunt for when the macro picture gets murky.